Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Ebola Virus VP30 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5112031

Catalog No. PIPA5112031


Only null left
Add to Cart

Description

Description

Ebola Virus VP30 Polyclonal Antibody for Western Blot, ICC/IF

Ebola virus disease (EVD) is a deadly disease with occasional outbreaks that occur primarily on the African continent. EVD most commonly affects people and nonhuman primates (such as monkeys, gorillas, and chimpanzees). It is caused by an infection with a group of viruses within the genusEbolavirus. VP30 is a phosphoprotein essential for the initiation of Ebola virus transcription, and plays a role in mutations in VP30 phosphorylation sites on the ebolavirus replication cycle by using a reverse genetics system.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Ebola Virus VP30
Polyclonal
Unconjugated
Ebola Virus
Recombinant protein encompassing a sequence within the N-terminus region of Ebola virus VP30 protein. The exact sequence is proprietary.
100 μL
Primary
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Western Blot
0.92 mg/mL
PBS with 20% glycerol and 0.025% ProClin 300; pH 7
Rabbit
Antigen affinity chromatography
RUO
Virus
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.